Vicore Pharma: Restoring lung function for IPF patients

12/12/2023 11 min Episodio 13
Vicore Pharma: Restoring lung function for IPF patients

Listen "Vicore Pharma: Restoring lung function for IPF patients"

Episode Synopsis

Hear Vicore Pharma’s CEO, Ahmed Mousa speak to Optimum's Richard Staines on their new treatment for Idiopathic Pulmonary Fibrosis (IPF), C21. It aims to improve available treatments for patients of IPF by halting the progression of fibrosis and has the aim of restoring lung function. Hosted on Acast. See acast.com/privacy for more information.

More episodes of the podcast Optimum Perspectives